Altered Expression Pattern of CD55 and CD59 on Red Blood Cells in Anemia of Chronic Kidney Disease
Authors:
Open Access
- 28 September 2017
- journal article
- research article
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 26 (6) , 516-522
Abstract
Objective: The aim of this study was to investigate the expression pattern of CD55 and CD59 on red blood cells (RBCs) in anemic chronic kidney disease (CKD) patients, and factors that might influence their expression. Subjects and Methods: Nighty-one adult anemic CKD patients and 80 healthy controls (HCs) were enrolled. Anemic CKD patients were divided into 3 subgroups based on receiving erythropoietin and renal replacement therapies. Flow cytometric analysis of CD55 and CD59 expression was performed on RBCs from blood samples obtained from CKD patients and HCs. Results: CD59 deficiency was significantly higher among CKD patients than HCs (n = 68, 74.7%, vs. n = 13, 16.3%, respectively; p < 0.001). The median proportions of CD55- and CD59-deficient RBCs in CKD patients were significantly higher compared to HCs (0.34 vs. 0.15, and 4.3 vs. 2.0, p < 0.001 and p < 0.001, respectively). The mean fluorescence intensity (MFI) of CD55 and CD59 expression was significantly lower in CKD patients compared to HCs (1.2 vs. 2.8, and 17.0 vs. 20.3, p < 0.04 and p < 0. 001, respectively). The hemoglobin level was inversely correlated with the proportions of CD55- and CD59-deficient RBCs (r = -0.37, p < 0.001, and r = -0.22, p < 0.02, respectively). The number of CD59-deficient patients was significantly different between the 3 subgroups of CKD patients (p = 0.001), and a significant difference was present in the MFI of CD55 and CD59 expression among the 3 subgroups (p = 0.04 and p = 0.03, respectively). Conclusion: The expression pattern of CD55 and CD59 on RBCs is altered in anemic CKD patients, which could play a role in the pathogenesis of anemia in CKD.Keywords
This publication has 26 references indexed in Scilit:
- Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometryCytometry Part B: Clinical Cytometry, 2010
- Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patientsCellular Immunology, 2010
- The prevalence of anemia in patients with chronic kidney diseaseCurrent Medical Research and Opinion, 2004
- Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria.2003
- Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro‐inflammatory cytokinesNephrology Dialysis Transplantation, 2001
- Increased susceptibility to erythrocyte C5b-9 deposition and complement-mediated lysis in chronic renal failureKidney International, 1999
- Complement RegulationVox Sanguinis, 1998
- Decay-Accelerating Factor: Biochemistry, Molecular Biology, and FunctionAnnual Review of Immunology, 1989
- The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietinKidney International, 1989
- Effect of parathyroid hormone on erythropoiesis.Journal of Clinical Investigation, 1981